Brief: Acer Therapeutics Receives $1 Million Capital Infusion From Chief Executive Officer And Founder
26/06/2023 14:01
June 26 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS RECEIVES $1 MILLION CAPITAL INFUSION
FROM
CHIEF EXECUTIVE OFFICER AND FOUNDER
* ACER THERAPEUTICS INC: PROMISSORY NOTE EXTENDS CASH RUNWAY
INTO
EARLY Q3 2023
* ACER THERAPEUTICS INC: OLPRUVA™ EXPECTED TO BE AVAILABLE
BY
PRESCRIPTION IN U.S. BEGINNING JULY 5
Source text for Eikon: ID:nGNX86nF4X
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31